Smith Thornton Advisors’s Eli Lilly LLY Stock Holding History

Smith Thornton Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.38M	Hold	1,189	–	–	0.6%	45
2026 Q2	$1.4M	Buy	1,189 +288	+32%	+$294K	0.62%	45
2026 Q1	$828K	Buy	901 +1	+0.1%	+$1.01K	0.42%	60
2025 Q4	$968K	Sell	900 -6	-0.7%	-$5.74K	0.49%	54
2025 Q3	$692K	Buy	906 +5	+0.6%	+$3.72K	0.36%	67
2025 Q2	$703K	Buy	901 +70	+8%	+$54.4K	0.4%	62
2025 Q1	$686K	Buy	831 +37	+5%	+$30.8K	0.43%	60
2024 Q4	$613K	Buy	794 +335	+73%	+$277K	0.39%	69
2024 Q3	$407K	Buy	459 +3	+0.7%	+$2.7K	0.27%	92
2024 Q2	$413K	Buy	+456	New	+$365K	0.3%	84

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Smith Thornton Advisors's LLY Position: Q3 2026 in Review

Smith Thornton Advisors held its Eli Lilly (LLY) position steady in Q3 2026 at 1,189 shares worth $1.38M. The position accounts for 0.6% of the portfolio, ranked #45.

Smith Thornton Advisors first reported a position in LLY in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.4M in Q2 2026. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Smith Thornton Advisors held 1,189 shares of Eli Lilly worth $1.38M as of Q3 2026.
Smith Thornton Advisors left its Eli Lilly share count unchanged in Q3 2026.
Eli Lilly made up 0.6% of Smith Thornton Advisors's portfolio in Q3 2026, its #45 holding.
Smith Thornton Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 10 quarters since.
Smith Thornton Advisors's Eli Lilly position peaked at $1.4M in Q2 2026.
2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Smith Thornton Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.